(KV)

Serial Number 97150686
732

Registration Progress

Application Filed
Dec 1, 2021
Under Examination
Mar 12, 2024
Approved for Publication
Jan 16, 2024
Published for Opposition
Jan 16, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Mar 12, 2026 67 days

Trademark Image

(KV)

Basic Information

Serial Number
97150686
Filing Date
December 1, 2021
Published for Opposition
January 16, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
732
Status Date
Sep 10, 2025
Application
Pending
Classes
005

Rights Holder

KALIVIR IMMUNOTHERAPEUTICS, INC.

03
Address
240 Alpha Drive
Pittsburgh, PA 15238

Ownership History

KALIVIR IMMUNOTHERAPEUTICS, INC.

Original Applicant
03
Pittsburgh, PA

KALIVIR IMMUNOTHERAPEUTICS, INC.

Owner at Publication
03
Pittsburgh, PA

Legal Representation

Attorney
DRAEKE H WESEMAN

USPTO Deadlines

Next Deadline
67 days remaining
NOA E-Mailed - SOU Required
Due Date
March 12, 2026
Extension Available
Until September 12, 2026

Application History

39 events
Date Code Type Description Documents
Sep 10, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 10, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 10, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 13, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 12, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 12, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 12, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 5, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 5, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 5, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 12, 2023 EXPT T EXPARTE APPEAL TERMINATED Loading...
Dec 12, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 5, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 5, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 25, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 25, 2023 EXPI T EX PARTE APPEAL-INSTITUTED Loading...
Oct 25, 2023 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Oct 25, 2023 EXAF T EXPARTE APPEAL RECEIVED AT TTAB Loading...
Jul 21, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jul 21, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Apr 25, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Apr 25, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Apr 25, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 21, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 20, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 20, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 19, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 19, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 19, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 10, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 7, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 6, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 4, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith

Additional Information

Design Mark
The mark consists of the letters "KV" between two parentheses with a slash across the letters.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005